Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immunovant Q1 EPS $(0.31) Misses $(0.30) Estimate

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 18.42 percent increase over losses of $(0.38) per share from the
byLuke J Jacobi
August 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) by 3.33 percent. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Stock Splits Led To Big Gains In Tesla And Apple, But Amazon Stock Has Underperformed: Will The E-Commerce Giant Try A Spinoff Next?

By Adam Eckert
Today, 9:36 PM
Stock splits have become increasingly popular among mega-cap companies with lofty share prices as splits often lead to increased attention and an appreciation in underlying stock prices, but Amazon.com Inc (NASDAQ: AMZN) has not seen said benefits since announcing a split in March.

AAPL